Literature DB >> 11789553

Assessing the reliability of the EORTC QLQ-C30 in a sample of older African American and Caucasian adults.

M E Ford1, S L Havstad, C S Kart.   

Abstract

The purpose of this study was to examine the structure and reliability of the EORTC QLQ-C30. This 30-item instrument has five functional scales (physical, role, cognitive, emotional, and social), three symptom scales (fatigue, pain, and nausea and vomiting) and a global health and quality of life scale. Confirmatory factor analysis and Cronbach's alpha estimates were used to assess the functioning of the EORTC QLQ-C30 in a sample of 489 African American (n = 255) and Caucasian (n = 234) adults aged 50 + years. Seven of the nine EORTC QLQ-C30 scales showed good reliability for both the African Americans and the Caucasians in the sample (Cronbach's alpha > 0.75). In contrast, the cognitive functioning scale had a reliability coefficient of only 0.69 for the African Americans and 0.40 for the Caucasians, and the nausea and vomiting scale had a reliability coefficient of only 0.49 for the African Americans and 0.51 for the Caucasians. In summary, although the overall reliabilities of seven of the scales showed good fit, many of the item-to-scale correlations did not. Researchers planning to use the EORTC QLQ-C30 might first consider conducting separate analyses on the different racial or ethnic subgroups in their study populations to determine whether a common set of factors or scales is available for further analysis.

Entities:  

Mesh:

Year:  2001        PMID: 11789553     DOI: 10.1023/a:1013003014340

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  29 in total

1.  The quality of life of patients with newly diagnosed M1 prostate cancer: experience with EORTC clinical trial 30853.

Authors:  F C da Silva; S D Fossa; N K Aaronson; S Serbouti; L Denis; J Casselman; P Whelan; J Hetherington; C Fava; B Richards; M R Robinson
Journal:  Eur J Cancer       Date:  1996-01       Impact factor: 9.162

Review 2.  Quality of life in prostate cancer: what are the issues and how are they measured?

Authors:  S D Fosså
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

3.  Race, socioeconomic status, and cause-specific mortality.

Authors:  G Howard; R T Anderson; G Russell; V J Howard; G L Burke
Journal:  Ann Epidemiol       Date:  2000-05       Impact factor: 3.797

4.  Computerized quality-of-life screening in an oncology clinic.

Authors:  P A Taenzer; M Speca; M J Atkinson; B D Bultz; S Page; P Harasym; J L Davis
Journal:  Cancer Pract       Date:  1997 May-Jun

5.  The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.

Authors:  M A Sprangers; M Groenvold; J I Arraras; J Franklin; A te Velde; M Muller; L Franzini; A Williams; H C de Haes; P Hopwood; A Cull; N K Aaronson
Journal:  J Clin Oncol       Date:  1996-10       Impact factor: 44.544

6.  Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3).

Authors:  M J Hjermstad; P M Fayers; K Bjordal; S Kaasa
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

7.  Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients.

Authors:  G Apolone; A Filiberti; S Cifani; R Ruggiata; P Mosconi
Journal:  Ann Oncol       Date:  1998-05       Impact factor: 32.976

8.  Symptom reporting in cancer patients: the role of negative affect and experienced social stigma.

Authors:  M Koller; J Kussman; W Lorenz; M Jenkins; M Voss; E Arens; E Richter; M Rothmund
Journal:  Cancer       Date:  1996-03-01       Impact factor: 6.860

9.  Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire.

Authors:  M J Hjermstad; S D Fossa; K Bjordal; S Kaasa
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

Review 10.  Comparison of instruments for measuring quality of life in patients with lung cancer.

Authors:  P J Hollen; R J Gralla
Journal:  Semin Oncol       Date:  1996-04       Impact factor: 4.929

View more
  5 in total

Review 1.  Choosing your partner for the PROM: a review of evidence on patient-reported outcome measures for use in primary and community care.

Authors:  Stirling Bryan; Jennifer Davis; James Broesch; Mary M Doyle-Waters; Steven Lewis; Kim McGrail; Margaret J McGregor; Janice M Murphy; Rick Sawatzky
Journal:  Healthc Policy       Date:  2014-11

2.  Health-related quality of life in Croatian general population and multiple myeloma patients assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 questionnaires.

Authors:  Sanja Ledinski Ficko; Vlatko Pejsa; Vesna Zadnik
Journal:  Radiol Oncol       Date:  2019-09-24       Impact factor: 2.991

3.  Evaluating the reliability of the Attitudes to Randomized Trial Questionnaire (ARTQ) in a predominantly African American sample.

Authors:  Marvella E Ford; Wei Wei; Leslie A Moore; Dana R Burshell; Kimberly Cannady; Franshawn Mack; Nnadozie Ezerioha; Kelley Ercole; Elizabeth Garrett-Mayer
Journal:  Springerplus       Date:  2015-08-12

4.  Prediction of long-term mortality by preoperative health-related quality-of-life in elderly onco-surgical patients.

Authors:  Maren Schmidt; Bruno Neuner; Andrea Kindler; Kathrin Scholtz; Rahel Eckardt; Peter Neuhaus; Claudia Spies
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

5.  European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30: factorial models to Brazilian cancer patients.

Authors:  Juliana Alvares Duarte Bonini Campos; Maria Cláudia Bernardes Spexoto; Wanderson Roberto da Silva; Sergio Vicente Serrano; João Marôco
Journal:  Einstein (Sao Paulo)       Date:  2018-04-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.